Ebola Cases Surge in Democratic Republic of Congo Amid Stretched Resources
The Democratic Republic of Congo is facing its largest Ebola outbreak, with over 9,000 confirmed cases and significant challenges in response efforts.

The Democratic Republic of Congo (DRC) is grappling with its largest and deadliest Ebola outbreak to date, reporting over 9,415 confirmed cases and 4,536 fatalities this year, according to the World Health Organization (WHO).
The virus has spread rapidly, resembling the severe outbreak in West Africa from 2014 to 2016, though this outbreak has not reached the same fatal levels. The latest data shows that within about 150 days of its onset, this year’s cases rose to 8,978, compared to 2,599 cases during the same period in 2014.
Numerous factors have made controlling the outbreak difficult. Heather Kerr, the country director for the International Rescue Committee in Congo, said funding cuts have severely impacted response efforts. “We had a lot more funding for the last outbreak,” she said, emphasizing the urgent need for more financial resources.
The outbreak is complicated by the strain of the Ebola virus involved, called Bundibugyo, which differs from previous strains. This strain lacks an effective vaccine and complicates treatment efforts. Kerr noted the importance of community trust, stating many people are too scared to seek treatment. As a result, most deaths occur outside healthcare facilities, further complicating containment efforts.
Kerr remarked, “So many of the deaths are in the community” due to fear and misinformation regarding the virus and treatment centers.
The DRC has had previous Bundibugyo outbreaks that were managed relatively quickly, but today’s situation is worsened by budgetary constraints and internal strife. The ongoing humanitarian crisis has left the healthcare system under-resourced. Millions face food insecurity, making populations highly vulnerable to disease.
Despite some international support, including a recent U.S. funding increase to over $265 million, much work remains to gain public trust and enhance the response to the outbreak. Kerr emphasized the role of community leaders in rebuilding trust to encourage individuals to seek treatment.
As emergency trials for a vaccine continue, the timeline for controlling the outbreak remains unclear. With nearly one-third of the infected population not receiving adequate care, public health officials are bracing for further challenges ahead.



